News

Biotheranostics to present feasibility data of gene expression profiling in blood

Biotheranostics, a leader in molecular diagnostics for cancer, announced results from a study developing a functional workflow for gene expression profiling using blood samples, providing insights into the potential for circulating tumor cell-based cancer classification that may help reduce dependency on tissue specimens. fundas iphone 11 pro fundas huawei p9 lite fundas iphone 6 6s plus fundas huawei y6 2018 coque iphone 6 fundas samsung galaxy s8 plus fundas samsung galaxy s20 plus fundas huawei mate 20 fundas samsung galaxy s8 plus fundas huawei mate 20 custodia cover samsung The study was presented at the American Association for Cancer Research (AACR) annual meeting, April 16-20, in New Orleans. fundas huawei p10 fundas iphone 11 fundas samsung galaxy a3 fundas huawei p10 fundas samsung galaxy note8 fundas iphone 6 6s custodia cover iphone fundas huawei p30 lite fundas samsung galaxy s8 fundas iphone 11 pro max iphone 8 hoesjes fundas samsung galaxy s4 “This initial research is an important first step for Biotheranostics as we evaluate the potential application of our proven cancer biomarkers in liquid biopsy diagnostics,” said Nicolas Barthelemy, President and CEO of Biotheranostics. fundas samsung galaxy s20 ultra fundas samsung galaxy s10 plus fundas huawei y7 2019 fundas huawei p30 fundas huawei p20 pro fundas samsung galaxy note5 fundas huawei mate 20 lite fundas huawei p8 lite 2017 fundas samsung galaxy note5 “Obtaining enough tissue from a biopsy or cytology specimen to perform diagnostic and biomarker testing can be challenging, and tissue conservancy is increasingly important in oncology given the number of emerging biomarkers. fundas samsung galaxy j3 fundas samsung galaxy s6 edge fundas huawei p smart 2019 fundas huawei p20 pro fundas huawei p8 lite fundas samsung galaxy note10 fundas huawei p20 pro fundas iphone 7 8 plus fundas samsung galaxy a40 We look forward to continued study of our CancerTYPE ID molecular test and its possible role in cancer classification using blood specimens.” In the analysis, technical feasibility studies for cancer cell enrichment and RNA viability were conducted by purifying cancer cells spiked into donor blood. fundas huawei mate 20 lite fundas huawei p8 lite 2017 fundas huawei p9 fundas samsung galaxy s5 fundas iphone 11 pro max fundas iphone 6 6s plus fundas samsung galaxy a70 fundas huawei y5 2019 Quantitative RT-PCR and immunoflourescence monitored cells harvested at different steps of the workflow, and gene expression profiling was performed using CancerTYPE ID. fundas samsung galaxy note10 fundas samsung galaxy note9 fundas iphone xs max fundas huawei y6 2019 fundas samsung galaxy a10 fundas iphone x xs fundas iphone 6 6s custodia cover fundas samsung galaxy s20 ultra Results showed that an integrated workflow was established that allows for molecular characterization of cancer cells purified from blood. fundas huawei p20 pro fundas samsung galaxy s8 fundas samsung galaxy j3 fundas huawei p10 fundas huawei p9 lite coque iphone xs fundas huawei y6 2019 The process resulted in efficient recovery of cells within the technical specifications of CancerTYPE ID. fundas samsung galaxy s6 edge plus fundas huawei p30 lite fundas samsung galaxy s20 ultra iphone 8 plus hoesjes iphone cover fundas huawei p20 The abstract, “Gene expression profiling for cancer classification in circulating tumor cells,” was presented as a poster session (Abstract No. fundas huawei y7 2019 coque samsung j3 fundas samsung galaxy a40 fundas iphone 11 fundas huawei p smart 2019 fundas huawei p30 pro fundas iphone 11 pro max fundas huawei mate 20 pro fundas huawei mate 20 pro 1391) Monday, April 18. fundas huawei mate 20 pro custodia cover samsung fundas huawei mate 10 lite fundas huawei y7 2019 fundas huawei mate 10 lite fundas huawei p10 lite fundas samsung galaxy s7 edge custodia huawei fundas huawei p30 lite fundas huawei mate 10 lite fundas samsung galaxy note10 plus fundas samsung galaxy s20 ultra coque iphone 8 Biotheranostics conducted the study in collaboration with Celsee Diagnostics, which provided the microfluidic chip for cancer cell enrichment and research support. custodia cover samsung fundas samsung galaxy s5 fundas huawei y6 2019 fundas huawei mate 20 lite fundas samsung galaxy s8 plus fundas huawei p30 lite fundas huawei y5 2018 fundas huawei p30 lite fundas huawei p smart 2019 fundas samsung galaxy s20 CancerTYPE ID is the market-leading gene expression-based test focused on the classification of metastatic cancer and is intended to aid in the diagnosis of the tumor type and subtype of cancers with diagnostic uncertainty, in conjunction with standard clinical and pathological assessment. fundas samsung galaxy s9 plus fundas samsung galaxy s20 ultra fundas samsung galaxy s20 fundas samsung galaxy note10 plus fundas huawei mate 20 lite fundas samsung galaxy note9 iphone 8 hoesjes fundas samsung galaxy note10 plus fundas samsung galaxy a50 fundas samsung galaxy s20 Commercially launched in 2010, CancerTYPE ID is a standardized, objective molecular test based on the differential expression of 92 genes that classifies tumors by matching the gene expression pattern of a tumor specimen to a database of known tumor types and histological subtypes. fundas huawei mate 10 fundas samsung galaxy a40 fundas samsung galaxy s6 fundas huawei mate 20 lite fundas huawei p30 lite fundas samsung galaxy s7 edge fundas huawei y6 2019 fundas huawei p9 fundas iphone xs max fundas iphone 11 CancerTYPE ID is able to classify 50 cancer types and subtypes, representing more than 95 percent of all solid tumors based on incidence. fundas samsung galaxy s10 fundas samsung galaxy s8 fundas huawei mate 20 pro fundas iphone 5 5s se fundas samsung galaxy s6 fundas iphone 11 pro max fundas samsung galaxy s7 fundas samsung galaxy a5 fundas iphone 11 pro custodia cover samsung About Celsee Diagnostics, Inc. Celsee Diagnostics, a privately held Michigan-based company, develops automated systems for rare CTC enrichment and single-cell analysis. fundas huawei p20 fundas huawei p9 bracelet femme custodia cover samsung fundas samsung galaxy s9 plus iphone 8 plus hoesjes fundas huawei p8 fundas samsung galaxy note5 fundas samsung galaxy a5 coque iphone 7 fundas huawei p8 The company’s precise, accurate, and reliable platform for research and clinical diagnostics development will allow healthcare professionals more time to focus on their patients’ therapeutic treatment and outcomes. fundas samsung galaxy note5 fundas samsung galaxy a3 fundas samsung galaxy s8 plus fundas samsung galaxy s8 plus custodia iphone fundas iphone 11 pro max fundas huawei p10 coque iphone 7 fundas iphone 11 pro max fundas iphone xs max fundas samsung galaxy j5 The label-free Celsee PREP platforms perform all the required processing steps to isolate and execute downstream single-cell analysis including immunochemistry, DNA FISH and mRNA FISH, while the Celsee ANALYZER scans and analyzes the prepared slide automatically. fundas huawei p20 lite fundas iphone 7 8 plus coque iphone xs fundas samsung galaxy a50 fundas huawei p10 lite For more information, visit celsee.com. fundas huawei p20 fundas huawei y5 2019 fundas iphone x xs fundas huawei y5 2019 custodia iphone cover fundas huawei p8 lite fundas samsung galaxy note8 fundas huawei y6 2017 custodia cover samsung fundas samsung galaxy note5 fundas samsung galaxy s10 fundas samsung galaxy note10 plus About Biotheranostics Biotheranostics, Inc., is a leader in helping physicians improve the care of cancer patients, offering a suite of proprietary molecular diagnostic tests that allow treatment to be tailored to individual patients. fundas samsung galaxy a3 fundas samsung galaxy s20 plus fundas huawei p smart fundas samsung galaxy s20 coque iphone 8 fundas iphone 11 fundas samsung galaxy s6 edge plus fundas huawei p20 fundas huawei p20 lite fundas samsung galaxy s7 The company’s CancerTYPE ID® is the most rigorously validated gene expression test for metastatic patients with diagnostic ambiguity, helping physicians determine optimal site-directed treatment regimens with the goal of improving patient outcomes. iphone hoesjes fundas huawei p8 lite 2017 iphone custodia cover fundas huawei mate 20 fundas huawei mate 10 lite fundas huawei p20 pro fundas huawei p20 fundas huawei p smart fundas huawei mate 10 fundas iphone 6 6s Its Breast Cancer Index℠ helps oncologists make difficult decisions about extended endocrine therapy for ER+ breast cancer patients based on its unique ability to predict risk of late disease recurrence and identify which patients are likely to benefit from continuing therapy beyond five years. fundas huawei mate 10 lite fundas samsung galaxy a5 iphone hoesjes fundas samsung galaxy a40 fundas samsung galaxy note10 plus Biotheranostics is based in San Diego. fundas huawei mate 20 fundas samsung galaxy s20 plus fundas huawei p10 lite fundas samsung galaxy s5 fundas iphone 7 8 plus fundas samsung galaxy a50 fundas samsung galaxy note9 bague femme Media Contact: Nicole Litchfield Bioscribe, Inc.